Rafferty Asset Management, LLC
Position in ARQT — Arcutis Biotherapeutics, Inc.
CIK 1389426
New York, NY
Position in ARQT
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$4,312,045
-$684,751 QoQ
Shares Held
183,024
+6.4% QoQ
Ownership
0.146%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2020
21 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in ARQT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Rafferty Asset Management, LLC holds $409,131,400 across 136 Biotechnology names. ARQT ranks #37 (1.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
54,572 | $24,368,580 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
29,589 | $22,861,644 | |
| 3 | INSM |
INSMED Inc
|
116,069 | $18,979,602 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
50,553 | $16,726,471 | |
| 5 | APLS |
Apellis Pharmaceuticals, Inc.
|
180,471 | $7,260,348 | |
| 6 | MRNA |
Moderna, Inc.
|
114,194 | $5,801,055 | |
| 7 | INCY |
Incyte Corp
|
60,565 | $5,700,377 | |
| 8 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
10,452 | $5,471,308 |
All Filings in ARQT
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $4,312,045 | 183,024 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $4,996,796 | 172,066 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $2,795,360 | 148,295 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $2,164,001 | 154,351 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $2,508,139 | 160,367 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $2,929,994 | 210,337 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $2,574,407 | 276,818 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $2,413,145 | 259,478 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $8,150,588 | 822,461 | Shares | Sole | 2024-05-13 | |
| 2023-09-30 | $2,226,530 | 419,309 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $4,764,256 | 499,922 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $3,351,766 | 304,706 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $4,486,309 | 303,129 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $3,324,815 | 173,983 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $903,053 | 42,377 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $1,102,808 | 57,259 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $1,179,069 | 56,850 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $722,027 | 30,223 | Shares | Sole | 2021-11-10 | |
| 2021-06-30 | $1,030,497 | 37,761 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $1,206,178 | 41,693 | Shares | Sole | 2021-05-10 | |
| 2020-12-31 | $212,747 | 7,563 | Shares | Sole | 2021-02-10 | |
| No filing history on record for this holder in this stock. | ||||||